Industry News
Data on more than 10,000 cancer genomes released by the International Cancer Genome Consortium
Feb 06, 2014
The International Cancer Genome Consortium (ICGC) has announced that it has made available to the scientific community data from more than 10,000 cancer genomes. The data can be used by cancer researchers around the world to better understand the genomic basis of cancer, accelerate cancer research and aid in the development of more targeted treatments. Read More
Dispelling myths can help prevent cancer deaths
Feb 06, 2014
On World Cancer Day, February 4, the Pan American Health Organization/World Health Organization (PAHO/WHO) is helping to "Debunk the myths" about cancer in collaboration with the Union for International Cancer Control (UICC). "Many people still think a cancer diagnosis is a death sentence and that cancer is an unavoidable disease," said PAHO Director Carissa F. Etienne. Read More
New approach prevents thrombosis without increasing the risk of bleeding
Feb 06, 2014
In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings. Read More
New approach prevents thrombosis without increasing the risk of bleeding
Feb 06, 2014
In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings. Read More
Nanomedicine testing with blood cells on a microchip
Feb 06, 2014
Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Read More
How cancer cells thrive in oxygen-starved tumors
Feb 06, 2014
A new study identifies the molecular pathway that enables cancer cells to grow in areas of a tumor where oxygen levels are low, a condition called hypoxia.The findings by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Read More
A model for studying cancer and immune diseases
Feb 06, 2014
The protein STAT1 is involved in defending the body against pathogens and for inhibiting tumour development. If the levels of the protein are out of balance, disease may result. Researchers at the University of Veterinary Medicine, Vienna have developed a mouse whose STAT1 levels can be modified at will, enabling the study of the involvement of STAT1 in various processes. Read More
A model for studying cancer and immune diseases
Feb 06, 2014
The protein STAT1 is involved in defending the body against pathogens and for inhibiting tumour development. If the levels of the protein are out of balance, disease may result. Researchers at the University of Veterinary Medicine, Vienna have developed a mouse whose STAT1 levels can be modified at will, enabling the study of the involvement of STAT1 in various processes. Read More
How a shape-shifting DNA-repair machine fights cancer
Feb 06, 2014
Maybe you've seen the movies or played with toy Transformers, those shape-shifting machines that morph in response to whatever challenge they face. It turns out that DNA-repair machines in your cells use a similar approach to fight cancer and other diseases, according to research led by scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab). Read More
Radiation's association with higher mortality highlighted by largest-ever study of 20-year survival among pediatric low-grade glioma patients
Feb 06, 2014
The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. Read More
Previous Page Next Page